1. Alpha interferon in the treatment of haematologic malignancies;Roth, M.S.; Foon, K.A.;Am JMed,1986
2. Clinical toxicity of interferons in cancer patients: a review;Quesada, JR, Talpaz; M, Rios; A, Kurzock; R, Gutterman; J.U.;7 Clin Oncol,1986
3. Nephrotic syndrome during treatment with interferon;Selby, P.; Kohn, J.; Raymond, J.; Judson, I.; McElwain, T.;BMJ,1985
4. Acute interstitial nephritis with the nephrotic syndrome following recombinant leucocyte A interferon therapy for mycosis fungoides;Averbuch, S.D.; Austin HA, III, Sherwin; SA, Antonovych; T, Bunn; PA, Longo; D.L.,1984
5. Haematologic remission and cytogenetic improvement induced by recombinant human interferon alpha in chronic myelogenous leukemia;Talpaz, M.; Kantarjian, H.M.; McCredie, K.; Trujillo, J.M.; Keating, M.J.; Gutterman, J.U.;N Engl 7 Med,1986